PRACHI DALAL: Open Payments
NPI 1134813900 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 31 payments from 20 companies in 2025. Trend: 2023 $243 · 2024 $968 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $162 |
| Alexion Pharmaceuticals, Inc. | 3 | $90 |
| Lilly USA, LLC | 3 | $79 |
| Lundbeck LLC | 2 | $69 |
| Biogen, Inc. | 2 | $58 |
| SK Life Science, Inc. | 2 | $58 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $49 |
| Octapharma USA, Inc. | 1 | $49 |
| Merz Pharmaceuticals, LLC | 1 | $36 |
| HARMONY BIOSCIENCES LLC | 1 | $35 |
Products named: Briviact, ULTOMIRIS, ZEPBOUND, VYEPTI, FIRDAPSE, PANZYGA, Xeomin, WAKIX.
Industry payments across CA — which companies pay providers there.
